CONTEXT: Little is known about the occurrence and severity of sleep disturbance and fatigue between patients with common cancer diagnoses. OBJECTIVES: Study purposes were to evaluate for differences in the occurrence rates of sleep disturbances and fatigue; evaluate for differences in the severity of sleep disturbance using both subjective and objective measures; and evaluate for differences in the severity of self-reported fatigue in patients with breast and prostate cancer at the initiation of radiation therapy (RT). METHODS: Patients with breast (n=78) and prostate (n=82) cancer were evaluated before the initiation of RT using the Pittsburgh Sleep Quality Index, General Sleep Disturbance Scale, Lee Fatigue Scale, and wrist actigraphy. Differences in sleep disturbance and fatigue between groups were evaluated using independent sample t-tests and Chi-square analyses. RESULTS: Occurrence rates for sleep disturbance (P<0.0001) and fatigue (P=0.03) were significantly higher in patients with breast compared with prostate cancer. Patients with breast cancer self-reported significantly higher levels of sleep disturbance (P=0.008) and fatigue (P=0.005) than patients with prostate cancer. However, using actigraphy, patients with prostate cancer had poorer sleep efficiency (P=0.02) than patients with breast cancer. CONCLUSION: Based on self-report, patients with breast cancer experience sleep disturbance more frequently and with greater severity than patients with prostate cancer. Objective measures of sleep disturbance suggest that prostate cancer patients have more severe sleep disturbance than breast cancer patients. All the patients experienced poor sleep quality and fatigue, which suggests that oncology patients need to be assessed for these symptoms.
CONTEXT: Little is known about the occurrence and severity of sleep disturbance and fatigue between patients with common cancer diagnoses. OBJECTIVES: Study purposes were to evaluate for differences in the occurrence rates of sleep disturbances and fatigue; evaluate for differences in the severity of sleep disturbance using both subjective and objective measures; and evaluate for differences in the severity of self-reported fatigue in patients with breast and prostate cancer at the initiation of radiation therapy (RT). METHODS:Patients with breast (n=78) and prostate (n=82) cancer were evaluated before the initiation of RT using the Pittsburgh Sleep Quality Index, General Sleep Disturbance Scale, Lee Fatigue Scale, and wrist actigraphy. Differences in sleep disturbance and fatigue between groups were evaluated using independent sample t-tests and Chi-square analyses. RESULTS: Occurrence rates for sleep disturbance (P<0.0001) and fatigue (P=0.03) were significantly higher in patients with breast compared with prostate cancer. Patients with breast cancer self-reported significantly higher levels of sleep disturbance (P=0.008) and fatigue (P=0.005) than patients with prostate cancer. However, using actigraphy, patients with prostate cancer had poorer sleep efficiency (P=0.02) than patients with breast cancer. CONCLUSION: Based on self-report, patients with breast cancer experience sleep disturbance more frequently and with greater severity than patients with prostate cancer. Objective measures of sleep disturbance suggest that prostate cancerpatients have more severe sleep disturbance than breast cancerpatients. All the patients experienced poor sleep quality and fatigue, which suggests that oncology patients need to be assessed for these symptoms.
Authors: Mogens Groenvold; Morten Aagaard Petersen; Ellen Idler; Jakob Bue Bjorner; Peter M Fayers; Henning T Mouridsen Journal: Breast Cancer Res Treat Date: 2007-01-03 Impact factor: 4.872
Authors: Sonia Ancoli-Israel; Roger Cole; Cathy Alessi; Mark Chambers; William Moorcroft; Charles P Pollak Journal: Sleep Date: 2003-05-01 Impact factor: 5.849
Authors: Maria Tejada; Carol Viele; Kord M Kober; Bruce A Cooper; Steven M Paul; Laura B Dunn; Marilyn J Hammer; Fay Wright; Yvette P Conley; Jon D Levine; Christine Miaskowski Journal: Sleep Date: 2019-10-09 Impact factor: 5.849
Authors: Anand Dhruva; Bradley E Aouizerat; Bruce Cooper; Steven M Paul; Marylin Dodd; Claudia West; William Wara; Kathryn Lee; Laura B Dunn; Dale J Langford; John D Merriman; Christina Baggott; Janine Cataldo; Christine Ritchie; Kord Kober; Heather Leutwyler; Christine Miaskowski Journal: Eur J Oncol Nurs Date: 2013-09-05 Impact factor: 2.398
Authors: Christina Van Onselen; Bruce A Cooper; Kathryn Lee; Laura Dunn; Bradley E Aouizerat; Claudia West; Marylin Dodd; Steven Paul; Christine Miaskowski Journal: Support Care Cancer Date: 2012-10 Impact factor: 3.603
Authors: Christine Miaskowski; Steven M Paul; Bruce Cooper; Claudia West; Jon D Levine; Charles Elboim; Deborah Hamolsky; Gary Abrams; Judith Luce; Anand Dhruva; Dale J Langford; John D Merriman; Kord Kober; Christina Baggott; Heather Leutwyler; Bradley E Aouizerat Journal: Eur J Oncol Nurs Date: 2014-01-29 Impact factor: 2.398
Authors: Christine Miaskowski; Yvette P Conley; Judy Mastick; Steven M Paul; Bruce A Cooper; Jon D Levine; Mitchell Knisely; Kord M Kober Journal: J Pain Symptom Manage Date: 2017-08-08 Impact factor: 3.612
Authors: Christina Van Onselen; Steven M Paul; Kathryn Lee; Laura Dunn; Bradley E Aouizerat; Claudia West; Marylin Dodd; Bruce Cooper; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2012-08-24 Impact factor: 3.612
Authors: Christine Miaskowski; Bruce Cooper; Steven M Paul; Claudia West; Dale Langford; Jon D Levine; Gary Abrams; Deborah Hamolsky; Laura Dunn; Marylin Dodd; John Neuhaus; Christina Baggott; Anand Dhruva; Brian Schmidt; Janine Cataldo; John Merriman; Bradley E Aouizerat Journal: J Pain Date: 2012-12 Impact factor: 5.820